PPB (Parts Per Billion) with Saturated Air

Pharmacotherapeutic group: L02AE01 - analogues of gonadotropin - releasing hormone. Pharmacotherapeutic group: L02AE02 - analogues of gonadotropin-releasing hormone. № 1. The main effect of pharmaco-therapeutic effects of lattice sampling antitumor effects, the use of appropriate doses hozerelinu provides effective action without clinically significant accumulation. Side effects and complications in the use of drugs: here body fluid retention, weight gain, hypertension, changes in menstrual cycle (sudden bleeding, amenorrhea), nausea, lattice sampling breast tenderness, fatigue, depression, headaches, insomnia, dizziness, irritability; hepatic dysfunction, thrombosis, thromboembolism, anaphylaxis and anaphylactic reactions, urticaria, erythema, chloasma, thrombophlebitis, pulmonary embolism, hirsutism, alopecia. Preparations of drugs: an implant for injections in 2 months by 6.6 mg or 3 months to 9.9 mg nasal spray, dosed 150 mg / dose to 17.5 ml (35 mg) in bottles number 1. to 3.6 mg in a syringe-applicator lattice sampling a lattice sampling mechanism number 1, cap. The main effect of pharmaco-therapeutic effects of drugs: an analog of natural gonadotropin - releasing hormone (SHG) with enhanced biological activity, after re-entry significantly inhibited secretion of gonadotropins and gonad steroids, for a complete inhibition of testicular testosterone synthesis, efficiency buserelinu identical orhiektomiyi (benefit is the reduction and reflexivity psychological stress for the patient). Indications for use drugs: progressive hormone dependent prostate cancer, status after surgical removal lattice sampling testicles to prevent the further decrease of testosterone. Indications for use drugs: inoperable or metastatic breast cancer or endometrial cancer (palliative treatment). Contraindications to the use lattice sampling drugs: hypersensitivity to the drug.